Robert Bourrel

931 total citations
51 papers, 708 citations indexed

About

Robert Bourrel is a scholar working on Epidemiology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Robert Bourrel has authored 51 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in General Health Professions and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Robert Bourrel's work include Healthcare Systems and Practices (8 papers), Health, Medicine and Society (7 papers) and Pregnancy and Medication Impact (5 papers). Robert Bourrel is often cited by papers focused on Healthcare Systems and Practices (8 papers), Health, Medicine and Society (7 papers) and Pregnancy and Medication Impact (5 papers). Robert Bourrel collaborates with scholars based in France and Netherlands. Robert Bourrel's co-authors include Maryse Lapeyre‐Mestre, Jean‐Louis Montastruc, N Vallier, P Fender, Agnès Sommet, H. Allemand, Christine Damase‐Michel, P. Ricordeau, Caroline Hurault‐Delarue and Alain Weill and has published in prestigious journals such as PLoS ONE, Pain and Annals of the Rheumatic Diseases.

In The Last Decade

Robert Bourrel

50 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Bourrel France 16 179 131 89 85 75 51 708
Igor Karp Canada 17 131 0.7× 157 1.2× 72 0.8× 55 0.6× 47 0.6× 45 958
Chandrasekar Gopalakrishnan United States 13 163 0.9× 71 0.5× 72 0.8× 61 0.7× 95 1.3× 28 553
RA Lawrenson United Kingdom 8 93 0.5× 165 1.3× 83 0.9× 72 0.8× 58 0.8× 13 895
Sana Ghaddar United States 5 150 0.8× 76 0.6× 56 0.6× 131 1.5× 63 0.8× 8 1.2k
Aurore Palmaro France 17 192 1.1× 134 1.0× 158 1.8× 110 1.3× 43 0.6× 42 1.2k
Yangqin Xun China 12 114 0.6× 50 0.4× 87 1.0× 75 0.9× 119 1.6× 34 798
D. Jordi Goldstein-Fuchs Belgium 3 148 0.8× 70 0.5× 54 0.6× 129 1.5× 62 0.8× 3 1.2k
Shinya Kimura Japan 13 108 0.6× 38 0.3× 197 2.2× 68 0.8× 100 1.3× 22 781
Carol R. Drinkard United States 14 233 1.3× 62 0.5× 67 0.8× 35 0.4× 39 0.5× 20 862
P R Hebert United States 12 242 1.4× 93 0.7× 69 0.8× 32 0.4× 86 1.1× 14 844

Countries citing papers authored by Robert Bourrel

Since Specialization
Citations

This map shows the geographic impact of Robert Bourrel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bourrel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bourrel more than expected).

Fields of papers citing papers by Robert Bourrel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bourrel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bourrel. The network helps show where Robert Bourrel may publish in the future.

Co-authorship network of co-authors of Robert Bourrel

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bourrel. A scholar is included among the top collaborators of Robert Bourrel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bourrel. Robert Bourrel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baricault, Bérangère, et al.. (2017). Consommation ambulatoire des antibiotiques à risque de résistances bactériennes en 2014 en France. Therapies. 72(5). 593–604. 2 indexed citations
2.
Lapeyre‐Mestre, Maryse, et al.. (2017). Generic antiretroviral drug use in HIV-infected patients: A cohort study from the French health insurance database. Therapies. 73(3). 257–266. 1 indexed citations
3.
Pugnet, G., L. Sailler, Jean‐Pascal Fournier, et al.. (2016). Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study. The Journal of Rheumatology. 43(12). 2162–2170. 20 indexed citations
5.
Pugnet, G., L. Sailler, Robert Bourrel, Jean‐Louis Montastruc, & Maryse Lapeyre‐Mestre. (2014). Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study. The Journal of Rheumatology. 42(2). 316–322. 21 indexed citations
6.
Sommet, Agnès, et al.. (2013). Différences de taux de substitution des médicaments génériques en Midi-Pyrénées en fonction des classes pharmaco-thérapeutiques. Revue d Épidémiologie et de Santé Publique. 61(6). 539–544. 3 indexed citations
7.
Fournier, Jean‐Pascal, Agnès Sommet, Robert Bourrel, et al.. (2012). Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. European Journal of Clinical Pharmacology. 68(11). 1533–1540. 42 indexed citations
8.
Gourraud, Pierre‐Antoine, et al.. (2010). Multiple sclerosis in Haute-Garonne: an important underestimate of prevalence.. Revue d Épidémiologie et de Santé Publique. 58(1). 23–31. 2 indexed citations
9.
Gourraud, Pierre‐Antoine, et al.. (2010). La SEP en Haute-Garonne : une sous-estimation importante du nombre de cas. Revue d Épidémiologie et de Santé Publique. 58(1). 23–31. 16 indexed citations
10.
Hurault‐Delarue, Caroline, Isabelle Lacroix, Robert Bourrel, Jean‐Louis Montastruc, & Christine Damase‐Michel. (2008). Prescriptions et délivrances d’anti-inflammatoires non stéroïdiens après le 6e mois de grossesse : impact d’une lettre d’information envoyée par les autorités de santé. La Presse Médicale. 37(5). 767–774. 9 indexed citations
11.
Weill, Alain, P. Ricordeau, N Vallier, et al.. (2008). L'analyse des prestations remboursées par l'assurance maladie : matériel et méthodes. Diabetes & Metabolism. 26. 49–54. 2 indexed citations
12.
Weill, Alain, P. Ricordeau, N Vallier, et al.. (2008). Les modalités de suivi des diabétiques non insulino traités en France métropolitaine durant l'année 1998. Diabetes & Metabolism. 26(24). 39–48. 8 indexed citations
13.
Brefel‐Courbon, Christine, et al.. (2008). Comparison of chronic analgesic drugs prevalence in Parkinson’s disease, other chronic diseases and the general population. Pain. 141(1). 14–18. 36 indexed citations
14.
Constantin, Arnaud, et al.. (2007). Impact of etanercept on the costs of rheumatoid arthritis (RA): Results from a French observational study. Joint Bone Spine. 75(1). 25–28. 8 indexed citations
15.
Constantin, Arnaud, et al.. (2007). Coût de la polyarthrite rhumatoïde en France : comparaison léflunomide/étanercept. Therapies. 62(2). 137–142. 4 indexed citations
16.
Vallier, N, et al.. (2006). Coût des trente affections de longue durée pour les bénéficiaires du régime général de l'assurance maladie en 2004. 37(4). 267–283. 15 indexed citations
17.
Bourrel, Robert, et al.. (2006). Profil des utilisateurs d’anti-inflammatoires non stéroïdiens. Therapies. 61(2). 109–114. 8 indexed citations
18.
Berchery, Delphine, et al.. (2003). Utilisation des héparines en médecine de ville : données de l’Assurance Maladie de Midi-Pyrénées. Therapies. 58(5). 431–437. 2 indexed citations
19.
Ricordeau, P., Alain Weill, N Vallier, et al.. (2000). L'épidémiologie du diabète en France métropolitaine. Diabetes & Metabolism. 26. 11–24. 47 indexed citations
20.
Weill, Alain, et al.. (2000). [Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998].. PubMed. 26 Suppl 6. 39–48. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026